Back to Search
Start Over
Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine.
- Source :
-
JGIM: Journal of General Internal Medicine . Mar2023, Vol. 38 Issue 4, p986-993. 8p. 2 Charts, 3 Graphs. - Publication Year :
- 2023
-
Abstract
- Background: Herpes zoster vaccination rates remain low despite longstanding national recommendations to vaccinate immunocompetent adults aged ≥ 50 years. The Advisory Committee on Immunization Practice (ACIP) updated its recommendations for recombinant zoster vaccine (RZV) in October 2021 to include immunocompromised adults aged ≥19 years. Objective: To assess practices, attitudes, and knowledge about RZV, barriers to recommending RZV, and likelihood of recommending RZV to patients with various immunocompromising conditions. Design: Mail and internet-based survey conducted from May through July 2020. Participants: General internists and family physicians throughout the USA. Main Measures: Survey responses. Key Results: The response rate was 66% (632/955). Many physicians were already recommending RZV to immunocompromised populations, including adults ≥50 years with HIV (67% of respondents) and on recombinant human immune modulator therapy (56%). Forty-seven percent of respondents both stocked/administered RZV and referred patients elsewhere, frequently a pharmacy, for vaccination; 42% did not stock RZV and only referred patients. The majority agreed pharmacies do not inform them when RZV has been given (64%). Physicians were generally knowledgeable about RZV; however, 25% incorrectly thought experiencing side effects from the first dose of RZV that interfere with normal activities was a reason to not receive the second dose. The top reported barrier to recommending RZV was experience with patients declining RZV due to cost concerns (67%). Most physicians reported they would be likely to recommend RZV to immunocompromised patients. Conclusion: Most primary care physicians welcome updated ACIP RZV recommendations for immunocompromised adults. Knowledge gaps, communication issues, and financial barriers need to be addressed to optimize vaccination delivery. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 08848734
- Volume :
- 38
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- JGIM: Journal of General Internal Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 162678461
- Full Text :
- https://doi.org/10.1007/s11606-022-07721-z